Avidimer Therapeutics
Founded Year
2003Stage
Series A | AliveTotal Raised
$3.5MLast Raised
$2.5M | 15 yrs agoAbout Avidimer Therapeutics
Avidimer Therapeutics is a Healthcare/Pharmaceuticals / Drugs company based in Ann Arbor, Michigan. Avidimer Therapeutics' investors include Flagship Ventures and North Coast Technology Investors.
Missing: Avidimer Therapeutics's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Avidimer Therapeutics's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Avidimer Therapeutics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Avidimer Therapeutics is included in 1 Expert Collection, including Biopharma Tech.
Biopharma Tech
5,241 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Avidimer Therapeutics Frequently Asked Questions (FAQ)
When was Avidimer Therapeutics founded?
Avidimer Therapeutics was founded in 2003.
Where is Avidimer Therapeutics's headquarters?
Avidimer Therapeutics's headquarters is located at P.O. Box 7735, Ann Arbor.
What is Avidimer Therapeutics's latest funding round?
Avidimer Therapeutics's latest funding round is Series A.
How much did Avidimer Therapeutics raise?
Avidimer Therapeutics raised a total of $3.5M.
Who are the investors of Avidimer Therapeutics?
Investors of Avidimer Therapeutics include Flagship Pioneering and North Coast Technology Investors.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.